Nigeria is set to delivery of the Republic of Madagascar’s herbal drug ‘COVID Organics (COV)’, which the country’s leaders said cures and prevents Coronavirus.
The Nation reported that Nigeria’s consignment has been sent to Equatorial Guinea from where it will be airlifted to Abuja.
It was gathered that African countries were divided into zones for ease of transportation, leading to freighting of Nigeria’s consignments to Equatorial Guinea.
The Presidential Task Force (PTF) on COVID-19 has been notified of the offer from Madagascar and arrangements are being made to bring Nigeria’s allocation to Abuja though some health officials are pushing for clinical trial of Covid Organics before being used in the country.
There reportedly is pressure on the Federal Government by different medical and scientific organizations to allow the National Institute for Pharmaceutical Research and Development (NIPRD) and the National Agency for Food and Drug Administration and Control (NAFDAC) to subject the drug to further analysis.
The Nation source said; “The consignments of the drug are being distributed to different countries in Africa based on zonal grouping. We have been told that Nigeria’s consignment is in Equatorial Guinea from where it will be airlifted to Abuja.
“Some countries like Tanzania, Congo-Brazzaville, Guinea-Bissau and Equatorial Guinea have subscribed to the drugs. Also, while South Africa has offered to conduct a scientific analysis of the drug, Senegal said it will subject it to clinical trial.
“I can assure you that the Federal Government will take the best decision on the drug in the overall interest of Nigerians.
“Before any food or drug can be administered in this country, there are certain protocols that must be followed. The government will not circumvent these protocols. We want solution; we want the best for Nigerians.”
It will be recalled that on April 28, the Chairman of the PTF on COVID-19, Mr. Boss Mustapha said the nation was ready to give Madagascar’s herbal drink a trial.
This is coming after the World Health Organisation (WHO) maintained that the efficacy of the drug was unproven.